Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

Raffi, François, Prof ; Jaeger, Hans, MD ; Quiros-Roldan, Eugenia, MD ; Albrecht, Helmut, Prof ; Belonosova, Elena, MD ; Gatell, Jose M, Prof ; Baril, Jean-Guy, MD ; Domingo, Pere, MD ; Brennan, Clare, DPT ; Almond, Steve, MMath ; Min, Sherene, MD

The Lancet infectious diseases, 2013-11, Vol.13 (11), p.927-935 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível